International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis

Author(s): Lyon Joanna

Issue: Nov/Dec 2012 - Volume 16, Number 6
View All Articles in Issue

Page(s): 456-460

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 1

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 2

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 3

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 4

Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Page 5

Download in electronic PDF format for $75

Abstract: This article provides a discussion on the current problem of drug shortages within the U.S. and how compounded preparations serve as the only safe option as a source of medications during the crisis. Included are literature reviews concerning the reasons behind the increase in drug shortages and an update on the problem.

Related Keywords: Joanna Lyon, drug shortages, drug safety, gray market drugs, U.S. Food and Drug Administration, DEA, drug contamination, active pharmaceutical ingredients

Related Categories: LEGAL, LITERATURE REVIEW, PROFESSIONAL ISSUES

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Drug Shortage Compounding: The Only Safe Medication Source in a Time of Crisis Lyon Joanna	Nov/Dec 2012 Pg. 456-460
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr	Sep/Oct 2017 Pg. 356
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr	Jul/Aug 2016 Pg. 351 View Sample
The Role of Compounding Pharmacists During Drug Shortages Ofei Kelvin	Jul/Aug 2022 Pg. 298-301
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 294-298
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr	Nov/Dec 2015 Pg. 487-488
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G	Jul/Aug 2015 Pg. 303-305
Allowing Compounding Pharmacies to Address Drug Shortages Broughel James	Mar/Apr 2022 Pg. 100-109
PreScription: Discontinued Drugs and Drug Shortages Allen Loyd V Jr	Mar/Apr 2011 Pg. 92
Basics of Compounding for Hazardous Drugs, Part 2: Regulation and Sources of Contamination Allen Loyd V Jr	Nov/Dec 2006 Pg. 446-448
PostScription: Drug Shortages and Discontinued Drugs: Their Effects on Healthcare Allen Loyd V Jr, Williams LaVonn A	Jul/Aug 2012 Pg. 350-351
PostScription: Drug Disposal: Compounding Pharmacists' Involvement in the Prevention of Prescription Drug Misuse and Abuse Williams LaVonn A	Nov/Dec 2011 Pg. 526-527
Veterinary Transdermal Medications: A to Z Davidson Gigi S	Mar/Apr 2003 Pg. 106-113
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs Dillon L R	Jan/Feb 2020 Pg. 30-36
PreScription: Drug Shortages and Discontinued Drugs Allen Loyd V Jr	Jul/Aug 2012 Pg. 268
PreScription: Compounding for Drug Shortages Allen Loyd V Jr	May/Jun 2013 Pg. 180
U.S. Food and Drug Administration Requests for Input on HR 3204 Enactment: The Drug Quality and Security Act of 2013 Miller David G	Jan/Feb 2014 Pg. 35-36
Finally: A Final U.S. Food and Drug Administration Memorandum of Understanding, but It's Flawed Brunner Scott	Jul/Aug 2020 Pg. 296-297
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake	Sep/Oct 2015 Pg. 377-380
Nominations of Difficult to Compound Drugs to the U.S. Food and Drug Administration--Pharmacy Compounding Advisory Committee: Part 1 Allen Loyd V Jr	Sep/Oct 2015 Pg. 389-390
Return to Top